TechCare Corp. Stock Price - TECR

Best deals to access real time data!
SMALL CAP BASIC
Monthly Subscription
for only
$29.03
SMALL CAP PRO
Monthly Subscription
for only
$43.59
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
$49.99
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
Techcare Corp. (QB) TECR Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.02 +4.00% 0.52 0.59 0.52 0.52 0.50 14:41:56
Bid Price Ask Price Spread Spread % News
0.52 0.59 0.07 11.86% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5 7,786 $ 0.5237 $ 4.08k 8.36k 0.10 - 1.50
Last Trade Time Type Quantity Stock Price Currency
14:41:56 4,614 $0.52 USD

Techcare Corp. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 11.51M 22.13M $ -1.53M - -7.50 2.61M
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
118 0.00% $ - 0.00% - -

more financials information »

Techcare Corp. (QB) News

Historical TECR Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.510.6950.4440.000054765k19k0.011.96%
1 Month0.6210.890.4440.0000065k7k-0.101-16.26%
3 Months0.381.500.370.00000126k9k0.1436.84%
6 Months0.701.500.100.00000126k7k-0.18-25.71%
1 Year0.701.500.100.00000126k7k-0.18-25.71%
3 Years0.701.500.100.00000126k7k-0.18-25.71%
5 Years0.701.500.100.00000126k7k-0.18-25.71%

Techcare Corp. (QB) Description

TechCare Corp. f/k/a BreedIT Corp. (the "Company"), completed its merger with Novomic Ltd., a company organized under the laws of the State of Israel. In connection with the merger, the Company implemented the following corporate actions: (i) changed its name to TechCare Corp.; (ii) a reverse split of its common stock on a 1:30 basis; and (iii) authorized 10 million shares of blank check preferred stock. TechCare is engaged in the design, development, manufacturing and commercialization of a unique platform enabling a variety of medical treatments utilizing its proprietary device that vaporizes liquids from a contained capsule into the treatment area for the treatment of head lice. Its first and principal product is its head lice treatment product is comprised of three key major components: Compressor, Head Cap and Treatment Capsule. The lice treatment solution has completed the development and prototype stages and the Company expects that in in or about Q4 2016 it should receive CE regulatory approval (European Union) and also expects to finalize preparations for establishing a mass production line for Capsules, which use readily available materials. In connection with the merger, there was a change in control and new management.



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.